Perceive Biotherapeutics, Inc.
Perceive Biotherapeutics, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration | Geographic Atrophy, age-related macular degeneration, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-17 | NCT06087458 | |
| Long-Term Follow Up of VOY-101 Non-nAMD Extension Study | eye disorder, macular degeneration, retinal degeneration, retinal disorder | Enrolling by invitation | Not stated | 2026-06-22 | NCT07660640 |